Close
Help




JOURNAL

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

119,410 Journal Article Views | Journal Analytics

Emerging Therapeutic Options for the Management of COPD

Submit a Paper



Publication Date: 09 Apr 2013

Type: Review

Journal: Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Citation: Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2013:7 7-15

doi: 10.4137/CCRPM.S8140

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.


Downloads

PDF  (538.25 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Libertas Academica
This is the fastest progress we have experienced from submission to acceptance.  Reviews are fast, pertinent, and instructive.  Every step of the process is visible and prompt, and every email is friendly and immediate.  In all, it is an excellent experience to be published in Libertas Academica.
Dr Jiang Wang (Sun Yat sen University, Guangzhou, P.R. China)
More Testimonials

Quick Links


New article and journal news notification services